Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) EBT Margin (2020 - 2025)

Bio Essence has reported EBT Margin over the past 6 years, most recently at 69.56% for Q4 2025.

  • For Q4 2025, EBT Margin rose 8824.0% year-over-year to 69.56%; the TTM value through Dec 2025 reached 47.27%, up 37479.0%, while the annual FY2025 figure was 47.27%, 53036.0% up from the prior year.
  • EBT Margin for Q4 2025 was 69.56% at Bio Essence, up from 9.5% in the prior quarter.
  • Over five years, EBT Margin peaked at 89.25% in Q4 2023 and troughed at 927.27% in Q1 2025.
  • A 5-year average of 145.84% and a median of 61.67% in 2022 define the central range for EBT Margin.
  • On a YoY basis, EBT Margin climbed as much as 90006bps in 2025 and fell as far as -84734bps in 2025.
  • Year by year, EBT Margin stood at 42.54% in 2021, then rose by 3bps to 41.19% in 2022, then surged by 317bps to 89.25% in 2023, then tumbled by -121bps to 18.68% in 2024, then soared by 472bps to 69.56% in 2025.
  • Business Quant data shows EBT Margin for BIOE at 69.56% in Q4 2025, 9.5% in Q3 2025, and 23.41% in Q2 2025.